Alignment Healthcare’s (ALHC) Outperform Rating Reiterated at William Blair

William Blair restated their outperform rating on shares of Alignment Healthcare (NASDAQ:ALHC) in a report issued on Friday,RTT News reports.

A number of other research firms have also issued reports on ALHC. Stephens reiterated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research note on Monday, February 24th. Stifel Nicolaus raised their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Finally, Barclays raised their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.25.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $15.69 on Friday. The company’s fifty day moving average is $13.50 and its 200-day moving average is $11.95. Alignment Healthcare has a 12 month low of $4.46 and a 12 month high of $15.85. The firm has a market cap of $3.01 billion, a price-to-earnings ratio of -20.38 and a beta of 1.50. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Andreas P. Wagner sold 14,878 shares of the stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $14.38, for a total value of $213,945.64. Following the completion of the sale, the insider now directly owns 200,885 shares of the company’s stock, valued at $2,888,726.30. This represents a 6.90 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00. Following the completion of the sale, the president now directly owns 1,606,097 shares of the company’s stock, valued at approximately $21,858,980.17. This trade represents a 1.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 441,002 shares of company stock valued at $5,772,726 in the last ninety days. Company insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. R Squared Ltd bought a new position in shares of Alignment Healthcare during the 4th quarter worth about $55,000. RiverPark Advisors LLC bought a new position in shares of Alignment Healthcare during the 4th quarter worth about $106,000. Tower Research Capital LLC TRC lifted its holdings in shares of Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after acquiring an additional 6,286 shares during the period. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare during the 4th quarter worth about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the 3rd quarter worth about $131,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.